Neoprobe has received Food and Drug Administration 510(k) clearance for its Quantix/OR intraoperative blood-flow measurement system. With the clearance, Neoprobe said it would begin clinical evaluation of Quantix/OR at U.S. institutions. Boston University Medical Center will be the first U.S. evaluation site for the system, according to Neoprobe of Dublin, OH.
By AuntMinnie.com staff writersSeptember 9, 2003
Related Reading
Neoprobe continues to trim losses, increases revenue, July 31, 2003
Neoprobe cuts loss, May 8, 2003
Neoprobe begins delivering Qauntix/OR, April 28, 2003
Neoprobe shows loss in 2002, February 20, 2003
Neoprobe launches Quantix, November 21, 2002
Copyright © 2003 AuntMinnie.com